JP Morgan Chase
MDXG icon

JP Morgan Chase’s MiMedx Group MDXG Stock Holding History

JP Morgan Chase’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-82,500
Closed -$510K – 5824
2018
Q3 		$510K Buy
82,500
+35,000
+74% +$158K ﹤0.01% 4271
2018
Q2 		$304K Sell
47,500
-52,500
-53% -$374K ﹤0.01% 4389
2018
Q1 		$697K Buy
100,000
+64,400
+181% +$750K ﹤0.01% 3866
2017
Q4 		$449K Buy
+35,600
New +$434K ﹤0.01% 4112
2017
Q1 		– Sell
-76,300
Closed -$676K – 5158
2016
Q4 		$676K Buy
+76,300
New +$686K ﹤0.01% 3614

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase's MDXG Position: Q2 2026 in Review

JP Morgan Chase increased its MiMedx Group (MDXG) stake by 169% in Q2 2026, buying an estimated $300K and bringing the position to 131,049 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #5104.

JP Morgan Chase first reported a position in MDXG in Q2 2013 and has held it in 42 quarters since. The position peaked at $21M in Q3 2014. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • JP Morgan Chase held 131,049 shares of MiMedx Group worth $512K as of Q2 2026.
  • JP Morgan Chase bought 82,271 MiMedx Group shares in Q2 2026, an estimated $300K.
  • MiMedx Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5104 holding.
  • JP Morgan Chase first reported a position in MiMedx Group in Q2 2013 and has held it in 42 quarters since.
  • JP Morgan Chase's MiMedx Group position peaked at $21M in Q3 2014.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.